SPY424.23-1.03 -0.24%
DIA343.03-1.27 -0.37%
IXIC14,088.64-85.50 -0.60%

Taysha Gene Therapies Posts Wider Q1 Net Loss

05/11/2021 04:39

08:26 AM EDT, 05/11/2021 (MT Newswires) -- Taysha Gene Therapies (TSHA) on Tuesday reported a Q1 net loss of $0.87 per share, compared with $0.50 loss per share a year ago. Analysts polled by Capital IQ had called for $0.64 loss per share.

The gene therapy company said it ended Q1 with $228.7 million of cash, and cash equivalents, which is expected to support planned operations into 2023.

The company did not report revenue for the quarter, in line with expectations.

Price: 20.52, Change: -0.68, Percent Change: -3.21